Thermo Fisher Scientific Launches New External Molecular Control Panel for the Analytical Evaluation of BCR-ABL Test Methods
FREMONT, Calif., Oct. 17, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel. The Acrometrix BCR-ABL Panel is intended for use as an external control panel for analytical validation of BCR-ABL test methods.
BCR-ABL is a biomarker for chronic myeloid leukemia, a persistent bone marrow cancer. Blood tests monitor the effectiveness of targeted drug therapy for chronic myeloid leukemia by detecting and quantitating the BCR-ABL gene. BCR-ABL RNA must be accurately quantitated to make critical, timely, patient treatment decisions. With the launch of the Acrometrix BCR-ABL Panel, laboratorians can now monitor assay performance at every clinical stage due to expanded dynamic range.
“The Acrometrix BCR-ABL Panel is the first full-process molecular control for challenging validated BCR-ABL assay performance, providing researchers and laboratorians with greater confidence utilizing a highly charactized product,” said Fernando Beils, vice president and general manager of Clinical Diagnostics for Thermo Fisher. “Additionally, this new molecular control panel is traceable to the new World Health Organization (WHO) standards for genetic reference panels for the quantitation of BCR-ABL. This provides assurance to laboratory staff that there is accuracy in the measurement of their assay results.”
The Acrometrix BCR-ABL Panel is available globally as a Research Use Only product, and is not intended for clinical use.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.
Media Contact Information:
Mary Gottenborg
Director, Marketing
510-979-5000
Mary.gottenborg@thermofisher.com
www.thermofisher.com/acrometrix
Secondary Contact Information:
Kathy Ruzich
Sr Manager, Marketing Communications
510-979-5157
Kathy.ruzich@thermofisher.com
SOURCE Thermo Fisher Scientific
